Peel Hunt restated their hold rating on shares of Horizon Discovery Group (LON:HZD) in a research note published on Thursday.
Separately, Numis Securities restated a buy rating on shares of Horizon Discovery Group in a research note on Monday, September 17th.
Shares of Horizon Discovery Group stock remained flat at $GBX 195 ($2.55) during midday trading on Thursday. 122,321 shares of the stock traded hands, compared to its average volume of 258,981. Horizon Discovery Group has a twelve month low of GBX 160 ($2.09) and a twelve month high of GBX 294 ($3.84).
Horizon Discovery Group Company Profile
Horizon Discovery Group plc, an integrated life science company, designs, manufactures, and applies gene editing and gene modulation to build cell models that harbour the genetics of human disease in the Americas, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company operates through Products, Services, and Leveraged Research and Development (R&D) segments.
Further Reading: Why do companies issue stock splits?
Receive News & Ratings for Horizon Discovery Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Horizon Discovery Group and related companies with MarketBeat.com's FREE daily email newsletter.